Loading clinical trials...
Loading clinical trials...
Determination of Asymmetrical Dimethylarginine (ADMA) Accumulation in End Stage Renal Disease
Conditions
Locations
1
United States
University of Michigan Health System
Ann Arbor, Michigan, United States
Start Date
July 1, 2006
Primary Completion Date
March 8, 2007
Completion Date
March 8, 2007
Last Updated
June 5, 2017
NCT02417740
NCT07241390
NCT07480265
NCT07073820
NCT06926660
NCT06876233
Lead Sponsor
University of Michigan
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions